CELL INTELLIGENCE · 肿瘤细胞治疗研究

构建一种高度通用、经优化的 TCR 双特异性支架，用于靶向肿瘤特异性肽-HLA 抗原

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

靶向 CD79b 的三种新型 CAR 用于非霍奇金淋巴瘤治疗的临床前开发及靶抗原丢失特征分析

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target

基于特异性、疗效和靶抗原丢失，CARLY3 代表了一种针对非霍奇金淋巴瘤的潜在新型 CAR 治疗。

ARI0003：共转导 CD19/BCMA 双靶向 CAR-T 细胞治疗非霍奇金淋巴瘤

ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma.

用于血液系统恶性肿瘤免疫治疗的双特异性和三特异性免疫细胞衔接器

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.

肾脏病学趋势：从虚无主义到抗体介导排斥反应的靶向治疗

Trends in Nephrology: From nihilism to targeted treatment of antibody-mediated rejection.